Age and the Risk of Ventricular Tachyarrhythmia in Patients With an Implantable Cardioverter-Defibrillator
JACC: Clinical Electrophysiology · 2023-07 · 9 (7) · 979-988
DOI: 10.1016/j.jacep.2022.11.020 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift JACC: Clinical Electrophysiology, 2023-07. Verfasst von Mehmet K Aktaş und 13 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Cardiovascular Research Center, University of Rochester, Rochester, New York, USA. Electronic address: mehmet_aktas@urmc.rochester.edu. Hauptthemen laut MEDLINE: Defibrillators, Implantable, Tachycardia, Ventricular, Cardiomyopathies. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: NHLBI NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
BACKGROUND: The benefit of implantable cardioverter-defibrillators (ICDs) in elderly patients is controversial. OBJECTIVES: The aims of this study were to evaluate the risk for ventricular tachyarrhythmia (VTA) and ICD shocks by age groups and to assess the competing risk for VTA and death without prior VTA. METHODS: The study included 5,170 primary prevention ICD recipients enrolled in 5 landmark ICD trials (MADIT [Multicenter Automatic Defibrillator Implantation Trial] II, MADIT-Risk, MADIT-CRT [MADIT Cardiac Resynchronization Therapy], MADIT-RIT [MADIT Reduce Inappropriate Therapy], and RAID [Ranolazine in High-Risk Patients With Implanted Cardioverter-Defibrillator]). Fine and Gray regression analysis was used to evaluate the risk for fast VTA (ventricular tachycardia ≥200 beats/min or ventricular fibrillation) vs death without prior fast VTA in 3 prespecified age groups:
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Clinical Cardiovascular Research Center, University of Rochester, Rochester, New York, USA. Electronic address: mehmet_aktas@urmc.rochester.edu.
- Clinical Cardiovascular Research Center, University of Rochester, Rochester, New York, USA.
- The Edith Wolfson Medical Center, Holon, affiliated with the Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Förderung
- NHLBI NIH HHS
- National Institutes of Health
Zitieren
APA
Aktaş, M. K., Younis, A., Saxena, S., Diamond, A., Ojo, A., Kutyifa, V., Steiner, H., Steinberg, J. S., Zareba, W., McNitt, S., Polonsky, B., Rosero, S. Z., Huang, D. T., & Goldenberg, I. (2023). Age and the Risk of Ventricular Tachyarrhythmia in Patients With an Implantable Cardioverter-Defibrillator. JACC: Clinical Electrophysiology, 9(7), 979-988. https://doi.org/10.1016/j.jacep.2022.11.020
Vancouver
Aktaş MK, Younis A, Saxena S, Diamond A, Ojo A, Kutyifa V, et al. Age and the Risk of Ventricular Tachyarrhythmia in Patients With an Implantable Cardioverter-Defibrillator. JACC: Clinical Electrophysiology. 2023;9(7):979-988. doi:10.1016/j.jacep.2022.11.020
BibTeX
@article{Akta2023,
author = {Aktaş, Mehmet K and Younis, Arwa and Saxena, Shireen and Diamond, Alexander and Ojo, Amole and Kutyifa, Valentina and Steiner, Hillel and Steinberg, Jonathan S and Zareba, Wojciech and McNitt, Scott and Polonsky, Bronislava and Rosero, Spencer Z and Huang, David T and Goldenberg, Ilan},
title = {Age and the Risk of Ventricular Tachyarrhythmia in Patients With an Implantable Cardioverter-Defibrillator},
journal = {JACC: Clinical Electrophysiology},
year = {2023},
volume = {9},
number = {7},
pages = {979--988},
doi = {10.1016/j.jacep.2022.11.020}
}
EUVIMED